| # | % | |||||
|---|---|---|---|---|---|---|
| 101 | SAGE THERAPEUTICS INC | 150,000 | 10,950,000 | 0.09% | ||
| 102 | FLUIDIGM CORP DEL | 11,935,000 | 10,398,000 | 0.09% | PRN | |
| 103 | ABBOTT LABS | 211,000 | 10,356,000 | 0.09% | ||
| 104 | SERES THERAPEUTICS INC | 246,645 | 10,236,000 | 0.09% | ||
| 105 | SPARK THERAPEUTICS INCORPORATED | 166,500 | 10,035,000 | 0.08% | ||
| 106 | Anacor Pharmaceuticals Inc | 129,000 | 9,988,000 | 0.08% | ||
| 107 | REDHILL BIOPHARMA LTD | 564,900 | 9,948,000 | 0.08% | ||
| 108 | LION BIOTECHNOLOGIES INC COM | 1,022,100 | 9,373,000 | 0.08% | ||
| 109 | INCYTE CORP | 4,250,000 | 8,712,000 | 0.07% | PRN | |
| 110 | INCYTE CORP SR CV NT0.375 18 | 4,250,000 | 8,622,000 | 0.07% | PRN | |
| 111 | ROKA BIOSCIENCE INC | 3,220,429 | 8,373,000 | 0.07% | ||
| 112 | ORASURE TECHNOLOGIES INC | 1,550,300 | 8,356,000 | 0.07% | ||
| 113 | ALLERGAN PLC | 25,000 | 7,587,000 | 0.06% | Call | |
| 114 | ALIMERA SCIENCES INC | 1,500,000 | 6,915,000 | 0.06% | ||
| 115 | IMPAX LABORATORIES INC | 150,000 | 6,888,000 | 0.06% | Call | |
| 116 | INVITAE CORP | 456,666 | 6,795,000 | 0.06% | ||
| 117 | PERNIX THERAPEUTICS HLDGS IN | 1,073,000 | 6,352,000 | 0.05% | ||
| 118 | Biotie Therapies Corp. | 268,672 | 5,365,000 | 0.04% | ||
| 119 | OREXIGEN THERAPEUTICS INC | 5,210,000 | 4,884,000 | 0.04% | PRN | |
| 120 | FATE THERAPEUTICS INC | 692,900 | 4,483,000 | 0.04% | ||
| 121 | AVALANCHE BIOTECHNOLOGIES IN | 250,000 | 4,060,000 | 0.03% | Call | |
| 122 | ARRAY BIOPHARMA INC | 500,000 | 3,605,000 | 0.03% | Call | |
| 123 | BIOLINERX LTD | 1,135,000 | 3,019,000 | 0.03% | ||
| 124 | MANNKIND CORP. | 450,000 | 2,561,000 | 0.02% | Put | |
| 125 | PDL BIOPHARMA INC | 380,000 | 2,443,000 | 0.02% | Call | |
| 126 | PTC THERAPEUTICS INC | 50,000 | 2,407,000 | 0.02% | Put | |
| 127 | SYNERGY PHARMACEUTICALS DEL | 250,000 | 2,075,000 | 0.02% | Call | |
| 128 | QLT INC | 500,000 | 2,065,000 | 0.02% | ||
| 129 | ELEVEN BIOTHERAPEUTICS INC | 731,600 | 2,063,000 | 0.02% | ||
| 130 | DICERNA PHARMACEUTICALS INC | 141,900 | 1,980,000 | 0.02% | ||
| 131 | CEMPRA INC | 50,000 | 1,718,000 | 0.01% | ||
| 132 | COGENTIX MED INC | 990,745 | 1,605,000 | 0.01% | ||
| 133 | VITAL THERAPIES INC | 75,000 | 1,583,000 | 0.01% | Put | |
| 134 | AMARIN CORP PLC | 350,000 | 861,000 | 0.01% | ||
| 135 | BIOMARIN PHARMACEUTICAL INC SR SB CONV NT 20 | 500,000 | 792,000 | 0.01% | PRN | |
| 136 | BIOMARIN PHARMACEUTICAL INC 0.75 10/15/2018 | 500,000 | 771,000 | 0.01% | PRN |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001172661-15-001654, filed 2015.08.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
